363 related articles for article (PubMed ID: 32599910)
1. An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.
Knuplez E; Marsche G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599910
[TBL] [Abstract][Full Text] [Related]
2. Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.
Hung ND; Sok DE; Kim MR
Inflamm Res; 2012 May; 61(5):473-83. PubMed ID: 22252240
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E derived peptides inhibit the pro-inflammatory effect of lysophosphatidylcholine.
Nankar SA; Prajapati JS; Pande AH
Protein Pept Lett; 2014; 21(2):101-7. PubMed ID: 24151883
[TBL] [Abstract][Full Text] [Related]
4. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
Sevastou I; Kaffe E; Mouratis MA; Aidinis V
Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis.
Kougias P; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
Med Sci Monit; 2006 Jan; 12(1):RA5-16. PubMed ID: 16369478
[TBL] [Abstract][Full Text] [Related]
6. Lysophospholipids: potential markers of diseases and infertility?
Fuchs B; Muller K; Paasch U; Schiller J
Mini Rev Med Chem; 2012 Jan; 12(1):74-86. PubMed ID: 22070693
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms of lysophosphatidylcholine in the development of diseases.
Liu P; Zhu W; Chen C; Yan B; Zhu L; Chen X; Peng C
Life Sci; 2020 Apr; 247():117443. PubMed ID: 32084434
[TBL] [Abstract][Full Text] [Related]
8. Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis.
Akerele OA; Cheema SK
Med Hypotheses; 2015 Dec; 85(6):754-60. PubMed ID: 26604024
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice with Experimental Sepsis.
Ahn WG; Jung JS; Kwon HY; Song DK
Inflammation; 2017 Apr; 40(2):537-545. PubMed ID: 28028754
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and atherogenic disease association of lysophosphatidylcholine.
Schmitz G; Ruebsaamen K
Atherosclerosis; 2010 Jan; 208(1):10-8. PubMed ID: 19570538
[TBL] [Abstract][Full Text] [Related]
11. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine.
Domeij H; Hua X; Su J; Bäcklund A; Yan Z; Frostegård AG; Haeggström JZ; Modéer T; Frostegård J
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():72-8. PubMed ID: 23391726
[TBL] [Abstract][Full Text] [Related]
12. Endothelins specifically recognize lysophosphatidylcholine micelles.
Sato A; Ebina K
J Pept Sci; 2013 Jun; 19(6):355-61. PubMed ID: 23576491
[TBL] [Abstract][Full Text] [Related]
13. Role of lysophosphatidylcholine (LPC) in atherosclerosis.
Matsumoto T; Kobayashi T; Kamata K
Curr Med Chem; 2007; 14(30):3209-20. PubMed ID: 18220755
[TBL] [Abstract][Full Text] [Related]
14. Regulation and function of endothelial glycocalyx layer in vascular diseases.
Sieve I; Münster-Kühnel AK; Hilfiker-Kleiner D
Vascul Pharmacol; 2018 Jan; 100():26-33. PubMed ID: 28919014
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholines inhibit human eosinophil activation and suppress eosinophil migration in vivo.
Knuplez E; Curcic S; Theiler A; Bärnthaler T; Trakaki A; Trieb M; Holzer M; Heinemann A; Zimmermann R; Sturm EM; Marsche G
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158686. PubMed ID: 32171907
[TBL] [Abstract][Full Text] [Related]
16. Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.
Olofsson KE; Andersson L; Nilsson J; Björkbacka H
Biochem Biophys Res Commun; 2008 May; 370(2):348-52. PubMed ID: 18371300
[TBL] [Abstract][Full Text] [Related]
17. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.
van Meeteren LA; Frederiks F; Giepmans BN; Pedrosa MF; Billington SJ; Jost BH; Tambourgi DV; Moolenaar WH
J Biol Chem; 2004 Mar; 279(12):10833-6. PubMed ID: 14732720
[TBL] [Abstract][Full Text] [Related]
18. Lysophospholipids: their generation, physiological role and detection. Are they important disease markers?
Fuchs B; Schiller J
Mini Rev Med Chem; 2009 Mar; 9(3):368-78. PubMed ID: 19275729
[TBL] [Abstract][Full Text] [Related]
19. Lysoplasmenylcholine increases neutrophil adherence to human coronary artery endothelial cells.
White MC; Rastogi P; McHowat J
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1467-71. PubMed ID: 17728394
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.
Plemel JR; Michaels NJ; Weishaupt N; Caprariello AV; Keough MB; Rogers JA; Yukseloglu A; Lim J; Patel VV; Rawji KS; Jensen SK; Teo W; Heyne B; Whitehead SN; Stys PK; Yong VW
Glia; 2018 Feb; 66(2):327-347. PubMed ID: 29068088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
